Home Halogens L-Lysine, 2-[(3-chloro-2-methylphenyl)amino]-3-pyridinecarboxylate (1:1)

L-Lysine, 2-[(3-chloro-2-methylphenyl)amino]-3-pyridinecarboxylate (1:1)

CAS No.:
55837-30-4
Catalog Number:
AG0039LP
Molecular Formula:
C19H25ClN4O4
Molecular Weight:
408.8792
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
95%
In Stock USA
United States
$141
- +
5g
95%
In Stock USA
United States
$491
- +
Product Description
Catalog Number:
AG0039LP
Chemical Name:
L-Lysine, 2-[(3-chloro-2-methylphenyl)amino]-3-pyridinecarboxylate (1:1)
CAS Number:
55837-30-4
Molecular Formula:
C19H25ClN4O4
Molecular Weight:
408.8792
MDL Number:
MFCD07364029
IUPAC Name:
2-(3-chloro-2-methylanilino)pyridine-3-carboxylic acid;(2S)-2,6-diaminohexanoic acid
InChI:
InChI=1S/C13H11ClN2O2.C6H14N2O2/c1-8-10(14)5-2-6-11(8)16-12-9(13(17)18)4-3-7-15-12;7-4-2-1-3-5(8)6(9)10/h2-7H,1H3,(H,15,16)(H,17,18);5H,1-4,7-8H2,(H,9,10)/t;5-/m.0/s1
InChI Key:
CVNFYQCHAWFYQI-ZSCHJXSPSA-N
SMILES:
OC(=O)c1cccnc1Nc1cccc(c1C)Cl.NCCCC[C@@H](C(=O)O)N
UNII:
06PW4M190R
Properties
Complexity:
407  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
408.156g/mol
Formal Charge:
0
Heavy Atom Count:
28  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
5  
Isotope Atom Count:
0
Molecular Weight:
408.883g/mol
Monoisotopic Mass:
408.156g/mol
Rotatable Bond Count:
8  
Topological Polar Surface Area:
152A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Bioequivalence of 250 mg lysine clonixinate tablets after a single oral dose in a healthy female Mexican population under fasting conditions. International journal of clinical pharmacology and therapeutics 20100501
Analgesic efficacy of lysine clonixinate, paracetamol and dipyrone in lower third molar extraction: a randomized controlled trial. Medicina oral, patologia oral y cirugia bucal 20090801
Lysine clonixinate versus dipyrone (metamizole) for the acute treatment of severe migraine attacks: a single-blind, randomized study. Arquivos de neuro-psiquiatria 20080601
Lysine clonixinate vs naproxen sodium for the acute treatment of migraine: a double-blind, randomized, crossover study. MedGenMed : Medscape general medicine 20050101
Extraction and LC determination of lysine clonixinate salt in water/oil microemulsions. Journal of pharmaceutical and biomedical analysis 20020201
Effect of lysine clonixinate on the pharmacokinetics and anticoagulant activity of phenprocoumon. Arzneimittel-Forschung 20011101
In vivo and in vitro effects of lysine clonixinate on nitric oxide synthase in LPS-treated and untreated rat lung preparations. Nitric oxide : biology and chemistry 20010401
Oral lysine clonixinate in the acute treatment of migraine: a double-blind placebo-controlled study. Arquivos de neuro-psiquiatria 20010301
[Effects of lysine clonixinate on platelet function. Comparison with other non-steroidal anti-inflammatory agents]. Medicina 20010101
Antispasmodic/analgesic associations in primary dysmenorrhea double-blind crossover placebo-controlled clinical trial. International journal of clinical pharmacology research 20010101
[Effect of nonsteroidal antiinflammatory drugs on colonic lipoxygenase and cyclooxygenase activities from patients with colonic neoplasia]. Medicina 20010101
Properties